Showing results (501-510 of 525) with videos related to
Sort By:
Pageof 53
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2025
Ribociclib-letrozole combination as an alternative for neoadjuvant chemotherapy in selected post-menopausal patients with luminal breast cancer (BOOG 2017-01)Anne F de Groot, Danielle Cohen, Joan B Heijns, et al.The Lancet. Oncology|December 10, 2020
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trialRenu R Bahadoer, Esmée A Dijkstra, Boudewijn van Etten, et al.Journal of the National Cancer Institute|March 11, 2021
Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial CancerCathalijne C B Post, Ellen Stelloo, Vincent T H B M Smit, et al.Nuclear Medicine Communications|May 3, 2023
Baseline and early digital [ 18 F]FDG PET/CT and multiparametric MRI contain promising features to predict response to neoadjuvant therapy in locally advanced rectal cancer patients: a pilot studyFloris A Vuijk, Shirin Feshtali Shahbazi, Wyanne A Noortman, et al.Plos One|February 9, 2018
Randomized trial of one-hour sodium bicarbonate vs standard periprocedural saline hydration in chronic kidney disease patients undergoing cardiovascular contrast proceduresJudith Kooiman, Jean-Paul P M de Vries, Jan Van der Heyden, et al.Breast Cancer Research : BCR|August 29, 2019
Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01)Stefanie de Groot, Hanno Pijl, Ayoub Charehbili, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2020
Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer - Results of the international randomized RAPIDO-trialMaxime J M van der Valk, Corrie A M Marijnen, Boudewijn van Etten, et al.The New England Journal of Medicine|October 2, 2014
Randomized feeding intervention in infants at high risk for celiac diseaseSabine L Vriezinga, Renata Auricchio, Enzo Bravi, et al.Obstetrical & Gynecological Survey|December 30, 2025
Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 TrialCathalijne C B Post, Stephanie M de Boer, Melanie E Powell, et al.The Lancet. Oncology|September 8, 2025
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trialCathalijne C B Post, Stephanie M de Boer, Melanie E Powell, et al.Pageof 53